Finance

Beta
Lists
NAMS:NASDAQ
NewAmsterdam Pharma Company NV
US$ २९.३३
-३.४६%
(-१.०५) 1D
US$ २९.३३
०.००% (०.००)
After hours
Closed: जुन १०, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAMS...
Open
US$ ३०.०४
High
US$ ३१.१३
Low
US$ २९.२९
Mkt. cap
३.४३ अरब
Avg. vol.
१५.३४ लाख
Volume
८.६१ लाख
52-wk high
US$ ४२.२०
52-wk low
US$ १७.६७
EPS
-US$ १.७७
Beta
०.०८
Shares outstanding
११.६९ करोड
No. of employees
१००
Open
US$ ३०.०४
High
US$ ३१.१३
Low
US$ २९.२९
Mkt. cap
३.४३ अरब
Avg. vol.
१५.३४ लाख
Volume
८.६१ लाख
52-wk high
US$ ४२.२०
52-wk low
US$ १७.६७
EPS
-US$ १.७७
Beta
०.०८
Shares outstanding
११.६९ करोड
No. of employees
१००
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to NAMS in the past 3 months
Strong Buy
Buy
9
Hold
1
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for NAMS in the last 3 months.
Highest
Current US$ २९.३३
US$ ६०.०० (+१०४.५७%)
Average
US$ ४७.८६ (+६३.१८%)
Lowest
US$ ३८.०० (+२९.५६%)
News stories
From sources across the web
About NewAmsterdam Pharma Company NV
CEO-
Employees१००
Founded२०१९
Headquarters-
Sector-
Websitenewamsterdampharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१.९१ करोड
३.४८ लाख
३२.०० हजार
३०.४० लाख
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२.७५ करोड
३.१० करोड
३.८६ करोड
३.८० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.७३ करोड
२.४५ करोड
२.७४ करोड
२.३५ करोड
Operating expense
५.४८ करोड
५.५५ करोड
६.६० करोड
६.१५ करोड
Total operating expenses
५.४८ करोड
५.५५ करोड
६.६० करोड
६.१५ करोड
Operating income
-३.५६ करोड
-५.५१ करोड
-६.६० करोड
-५.८४ करोड
Other non operating income
२५.९० लाख
-२.३८ करोड
-१.५३ करोड
५९.४२ लाख
EBT including unusual items
-१.७४ करोड
-७.२० करोड
-७.४९ करोड
-४.८४ करोड
EBT excluding unusual items
-१.७४ करोड
-७.२० करोड
-७.४९ करोड
-४.८४ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.७४ करोड
-७.२० करोड
-७.४९ करोड
-४.८४ करोड
Net profit margin
-९०.७०%
-२०,६९१.०९%
-२,३४,१३४.३८%
-१,५९३.४५%
Earnings per share
-
-
-
-
Interest and investment income
७०.५५ लाख
६७.१३ लाख
६४.७३ लाख
५६.५० लाख
Interest expense
-
-
-
-
Net interest expenses
७०.५५ लाख
६७.१३ लाख
६४.७३ लाख
५६.५० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.५६ करोड
-५.५१ करोड
-६.५९ करोड
-५.८४ करोड
Gain or loss from assets sale
-
१.०० हजार
११.०० हजार
१२.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer